| NCT06079138 | Tele-rehabilitation Using TDCS Combined with Exercise in People with Spinal Cord Injury | Mahidol University | | - Age 18 - 70 yrs
- Level C1-S5
AIS - 1 months - 30 months
- NOT have unstable cardiopulmonary disease
- NOT have intracranial metal implantation, cochlear implant, or cardiac pacemaker
- NOT have a history of other neurological diseases, brain surgery, or epilepsy
| Ended | 30 | NA | Technology | Arm/hand function | - American Spinal Injury Association Impairment Scale (AIS)
- Ashworth and Modified Ashworth Scale (MAS)
- International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)
- Spinal Cord Independence Measure (SCIM)
- World Health Organization Quality of Life- BREF (WHOQOL-BREF)
| 2 months | 30 October 2023 | 12 October 2023 | 1 | |
| NCT06140706 | Feasibility of Home Based Transcutaneous Spinal Cord Stimulation for Persons With SCI | VA Palo Alto Health Care System | Single Group Assignment | - Age 18 - 75 yrs
- Level C2-C8
AIS B, C, D- ≥ 1 years
- NOT have cardiopulmonary disease or cardiac symptoms
- NOT have implanted medical devices
| Recruiting soon | 10 | Not Applicable | Technology | Arm/hand function | - Canadian Occupational Performance Measure
- Capabilities of Upper Extremity Instrument (CUE- Q and CUE-T)
- Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP)
- Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0)
| 4 months | 01 January 2024 | 20 November 2023 | 1 | |
| NCT03910101 | Long-term Efficacy of Spasticity-correcting Surgery and Botulinum Toxin Injections for Upper Limb Spasticity Treatment | Vastra Gotaland Region | | - Age ≥ 18 yrs
- Level C1-S5
AIS A, B, C, D- ≥ 6 months
| Ended | 34 | NA | Surgery | Spasticity | - Ashworth and Modified Ashworth Scale (MAS)
- Canadian Occupational Performance Measure
- Grasp and Release Test (GRT)
| 6 months | 25 January 2019 | 10 April 2019 | 1 | |
| NCT06094205 | Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02) | Massachusetts General Hospital | | - Age 18 - 80 yrs
- Level C1-T1
AIS - ≥ 12 months
| Recruiting | 2 | NA | Technology | Mental health and psychosocial factors | | 1-5 years | 16 October 2023 | 23 October 2023 | 2 | |
| NCT05730049 | Neuromodulation as an Anti-inflammatory Treatment in SCI | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | | - Age ≥ 18 yrs
- Level C1-S5
AIS - All
- NOT have implanted device, e.g., pacemaker.
| | 30 | NA | Technology | General health | | 24 hours | 01 January 2024 | 15 February 2023 | 1 | |
| NCT06072001 | Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis | Apurano Pharmaceuticals GmbH | Parallel Assignment | - Age ≥ 18 yrs
- Level C1-S5
AIS - All
- NOT have a history of addiction.
- understand German.
| Recruiting | 558 | Phase 3 | Drug | Pain | - Brief Pain Inventory (BPI)
- Depression Anxiety Stress Scale-21 (DASS-21)
- Neuropathoc Pain Symptom Inventory (NPSI)
- Pain Numeric Rating Scale (NRS)
| 52 weeks | 02 November 2023 | 10 October 2023 | 1 | |
